PlasmaLyte, Lactated Ringer's, or Normal Saline resuscitation in acute pancreatitis: a single-center, pragmatic, cluster-randomized trial.
- 1Division of Gastroenterology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.
- 2Division of Gastroenterology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. [email protected].
Abstract
Background/aims
The optimal resuscitation fluid for acute pancreatitis (AP) remains uncertain. This study evaluated the effects of PlasmaLyte (PL), Lactated Ringer's solution (LR), and Normal Saline (NS) in patients with early AP.Methods
A single-center, pragmatic, unblinded, monthly cluster-randomized trial compared PL, LR, and NS in patients with AP who presented within 6 h of symptom onset and had no evidence of overt severe disease at enrollment. The primary outcome was the change in systemic inflammatory response syndrome (SIRS) prevalence at 24 h. Secondary outcomes included clinical outcomes and biochemical changes after fluid resuscitation.Results
Sixty-six patients were enrolled (PL 21, LR 24, NS 21). Baseline SIRS prevalence was 23.8% in the PL group, 29.2% in the LR group, and 19.0% in the NS group; at 24 h, SIRS prevalence decreased to 4.8%, 12.5%, and 9.5%, respectively. This corresponded to relative reductions of 80.0% in PL, 57.1% in LR, and 50.0% in NS, without a statistically significant between-group difference (P = 0.668). No significant differences were observed in major clinical outcomes. At 24 h, potassium was higher in PL than in LR, chloride was higher in NS than in PL, and pH, bicarbonate, and base excess were lower in NS than in balanced crystalloid groups. These biochemical differences should be interpreted cautiously because of the small sample size and cluster design.Conclusions
In this small pragmatic trial, PL, LR, and NS showed no significant difference in the primary clinical endpoint. However, balanced crystalloids were associated with more favorable acid-base profiles than NS. These findings are exploratory and hypothesis-generating and require confirmation in larger multicenter trials with appropriate cluster-adjusted or individually randomized designs.Trial registration
Clinical Research Information Service (CRIS), KCT0007422. Registered June 20, 2022, https://cris.nih.go.kr .
Related
- Positive end-expiratory pressure versus sham valve/zero end-expiratory pressure in cardiopulmonary resuscitation during manual ventilation toimprove neurological outcomes in adult patients suffering an out-of-hospital cardiac arrest - an investigator-initiated, pragmatic, registry-based, multicenter, parallel-group, triple-blind randomized controlled superiority clinical trial in the ARREST registry (REVIVE-PEEP protocol Stage-1 Registered Report)
- Evaluation of the Caval-Aortic Index During Early Fluid Resuscitation in Patients With Acute Pancreatitis.
- Effect of capillary refill time-guided resuscitation on early fluid administration and fluid balance in septic shock: a single-center randomized controlled trial
- Telerehabilitation vs. centre-based cardiac rehabilitation after acute coronary syndrome: results of the pragmatic TELECOR randomized trial
- Pro-inflammatory cytokines moderated by visceral adiposity from a pragmatic randomized crossover trial of portable HEPA air purifiers
BibTeX
@article{sin2026plasmalyte,
title = {{PlasmaLyte, Lactated Ringer's, or Normal Saline resuscitation in acute pancreatitis: a single-center, pragmatic, cluster-randomized trial.}},
author = {Seung-Ho Sin and Hyung-Keun Kim and Hyun-Ho Choi and Sung-Soo Kim},
journal = {BMC gastroenterology},
year = {2026},
month = jul,
doi = {10.1186/s12876-026-05172-y},
url = {https://europepmc.org/article/MED/42897479},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - PlasmaLyte, Lactated Ringer's, or Normal Saline resuscitation in acute pancreatitis: a single-center, pragmatic, cluster-randomized trial.
AU - Seung-Ho Sin
AU - Hyung-Keun Kim
AU - Hyun-Ho Choi
AU - Sung-Soo Kim
PY - 2026
DA - 2026/07/01
JO - BMC gastroenterology
DO - 10.1186/s12876-026-05172-y
UR - https://europepmc.org/article/MED/42897479
AB - Background/aims The optimal resuscitation fluid for acute pancreatitis (AP) remains uncertain. This study evaluated the effects of PlasmaLyte (PL), Lactated Ringer's solution (LR), and Normal Saline (NS) in patients with early AP.Methods A single-center, pragmatic, unblinded, monthly cluster-randomized trial compared PL, LR, and NS in patients with AP who presented within 6 h of symptom onset and had no evidence of overt severe disease at enrollment. The primary outcome was the change in systemic inflammatory response syndrome (SIRS) prevalence at 24 h. Secondary outcomes included clinical outcomes and biochemical changes after fluid resuscitation.Results Sixty-six patients were enrolled (PL 21, LR 24, NS 21). Baseline SIRS prevalence was 23.8% in the PL group, 29.2% in the LR group, and 19.0% in the NS group; at 24 h, SIRS prevalence decreased to 4.8%, 12.5%, and 9.5%, respectively. This corresponded to relative reductions of 80.0% in PL, 57.1% in LR, and 50.0% in NS, without a statistically significant between-group difference (P = 0.668). No significant differences were observed in major clinical outcomes. At 24 h, potassium was higher in PL than in LR, chloride was higher in NS than in PL, and pH, bicarbonate, and base excess were lower in NS than in balanced crystalloid groups. These biochemical differences should be interpreted cautiously because of the small sample size and cluster design.Conclusions In this small pragmatic trial, PL, LR, and NS showed no significant difference in the primary clinical endpoint. However, balanced crystalloids were associated with more favorable acid-base profiles than NS. These findings are exploratory and hypothesis-generating and require confirmation in larger multicenter trials with appropriate cluster-adjusted or individually randomized designs.Trial registration Clinical Research Information Service (CRIS), KCT0007422. Registered June 20, 2022, https://cris.nih.go.kr .
SN - 1471-230X
ER -